March 11, 2015
Pharmapack Europe 2014
The thirteenth edition of the Pharmapack Europe event will take place on 12-13 February 2014 at Paris Expo, Porte de Versailles. More than 3,000 visitors and 330 exhibitors from over 70 countries will gather in the new exhibition hall to review the latest innovations and trends in packaging and delivery systems for medications and healthcare products.
For several years, the event was held in the north of Paris, initially at the Cité des Sciences and, subsequently, at the Grande Halle de la Villette, where it grew into a major event. Now, Pharmapack Europe is moving to the Porte de Versailles, in the south of the French capital. This change of location is a natural consequence following the success of the 2013 edition, which drew a record-breaking 3,000 visitors and 305 exhibitors. "As we expect even greater numbers of participants for the 2014 edition, we have opted for a larger space capable of accommodating around 330 exhibitors. In addition, this new site is located at the edge of central Paris and offers easy access, enabling the event to pursue its international development by providing more extensive top-quality services and facilities to suit professionals arriving from throughout the world", explains Aurore Domange, Event Manager of Pharmapack Europe. In this new location, as at previous editions, visitors to the event will find the same convivial atmosphere that has proven so conducive to effective networking and productive discussions of ongoing and forthcoming projects.
Meeting current expectations and planning for the future
As the leading European conference and exhibition in the field of pharmaceutical packaging and drug delivery systems, Pharmapack Europe remains true to its primary objective: to reflect the issues of concern to healthcare industry stakeholders and to showcase the major trends in the sector, both in terms of emerging markets and technological innovation. "The event's logo has thus been updated to highlight the growing importance of delivery systems, in particular for injectable treatments, which account for around 80% of the healthcare products currently in development.
These systems, which constitute an essential part of a medication and its packaging, represent a market that is growing strongly and driving innovation forward", states Aurore Domange. In keeping with its aim to meet the expectations of the healthcare industry, Pharmapack Europe will offer, once again, an edition packed with new features, as well as a top-quality conference and technical symposium programme alongside a first-rate exhibition.
The theme for the 2014 edition will be compliance and safety. These topics, which are central to current public healthcare challenges, will be addressed by an international panel of industrial, institutional and academic specialists. It is important to note that the 2014 conference programme will provide an opportunity for patient associations, as well as medication manufacturers, packaging specialists and healthcare professionals (hospital pharmacists, doctors, etc.), to express their needs with respect to the new packaging and delivery solutions put forward. "Pharmapack Europe is a showcase for technology and an incubator for innovations in packaging and drug delivery for healthcare products. The event brings together key healthcare stakeholders and offers the opportunity to consider the trends and innovations of the future, taking into account the difficulties faced by carers, patients, medication manufacturers and providers of solutions, from the design phase through to finished products", emphasises Aurore Domange.
Semi-scientific conferences focused on innovation
The 2014 conference programme will highlight the latest innovations in packaging and drug delivery systems intended to improve compliance and delivery of treatments, as well as the safety of patients and carers. More generally, top-level presentations will provide a comprehensive overview of changes to regulations, new market trends, and technological progress towards more effective solutions in terms of reducing costs and environmental impact. Particular emphasis will be given to innovation in delivery systems for injectables.
All of these issues will be addressed during four thematic sessions chaired by well renowned experts:
Session 1 - Drug Delivery and Drug/Device Combination Products
- Joel Richard, Ph.D., Vice President, Peptides, CMC & Engineering, IPSEN
- Dr. Yves T. Tillet, CEO, White-Tillet Consultants & Experts
Session 2 - Packaging of Liquid and Injectable Forms
- Franck Pavan, Business Development Manager, Aquitaine Pharm International, Pierre Fabre Médicament Production
- Jean-Louis Saubion, Hospital Pharmacist, Clinical Trials Coordinator, Hôpital Universitaire de Bordeaux
Session 3 - Packaging: Proper medicinal drug use and patient safety
- Prof. Philippe Arnaud, Hospital Pharmacist, Pharmacy Department Manager - Hôpital Bichat-Claude Bernard AP-HP, ANSM expert.
- David Dronneau, Technology, Innovation, Process & Solutions Manager in R&D Clinical Supplies, Sanofi
Session 4 - Future Healthcare Packaging: Materials, Sustainability and Collaborative Innovation
- Patrick Vuillermoz, General Manager, Plastipolis
- Dr. Pascal Bezou, R&D Scientific Project Manager/IV Set Project Manager, B. Braun Medical SAS
Technical symposium for better implementation of serialisation and Track & Trace
This year, the technical symposium returns with an entire day dedicated to serialisation and Track & Trace, entitled "How to understand and deploy all aspects of Track & Trace in the pharmaceutical industry". This has proven to be a major issue of late. A series of presentations and round tables will enable participants to discuss the technological and regulatory challenges of implementing serialisation and Track & Trace with the sector's experts. These meetings with experts will also offer manufacturers of healthcare products the opportunity to seek answers to the problems that they encounter in the field.
Wide-ranging expertise for the pharmaceutical packaging supply chain
Pharmapack Europe 2014 will bring together more than 330 suppliers and subcontractors from four continents, in a newly refurbished exhibition hall. The number of companies exhibiting has increased by 10 percent relative to 2013.
The loyalty rate is also on the up, with 85 percent of exhibitors returning this year. Likewise, the proportion of international exhibitors is growing and is forecast at 65percent for 2014, with record participation from German-speaking countries (Germany, Switzerland and Austria). The exhibition, which will welcome 63 new companies, is enhancing its scope, in particular with companies specialising in polymers, injection moulding for injectable delivery systems and medical devices, labelling systems and serialisation. These expertise, which are developing in parallel with the current trends in the sector, complements the existing range of knowledge on show at Pharmapack Europe, which includes the design and manufacture of primary, secondary and tertiary packaging as well as drug delivery systems.
Another new feature at Pharmapack Europe 2014 will be an Innovation Gallery, located in the exhibition area. This showcase will focus on the latest innovations developed by the exhibitors, including the products put forward for the Pharmapack Awards. Intended as a technological intelligence tool, the Innovation Gallery will enable decision-makers from laboratories and the medical industry (including managers in R&D, purchasing, procurement, production and business development) to gain a comprehensive and instant overview of the new solutions available on the market.
Pharmapack Awards 2014: rewarding and promoting innovation
One of the most awaited moments of Pharmapack Europe 2014 is the Pharmapack Awards ceremony, which will take place at the end of the first morning of the exhibition. The judging panel will present awards for medications, medical devices, healthcare products and veterinary medicines marketed between January and December 2013. Particular attention will be paid to progress in smart packaging and to innovations that result in significant improvements to the correct use of medications and compliance with treatments. Entries must be submitted to UBM Canon ([email protected]) before 23 December 2013.
Source: UBM Canon
About the Author(s)
You May Also Like